New Developments in the Treatment and Management of Pituitary Disorders

Niki  Hamblin(University of Ljubljana, Faculty of Medicine, Institute of Pharmacology and Experimental Toxicology, Korytkova ulica 2, Ljubljana, Slovenia)
Giammarco  Monteleone(University of Ljubljana, Faculty of Medicine, Institute of Pharmacology and Experimental Toxicology, Korytkova ulica 2, Ljubljana, Slovenia)

Abstract

Pituitary disorders encompass a wide range of conditions that affect the function of the pituitary gland, leading to imbalances in hormone production and subsequent systemic effects. Advances in medical technology and increased understanding of the pathophysiology of these disorders have led to significant improvements in their treatment and management. This review aims to provide an up-to-date overview of the latest developments in the field, focusing on the most effective diagnostic and therapeutic strategies. The study begins with a discussion of the diagnostic tools that are now available, such as advanced imaging techniques and sensitive assays for hormone measurement. These methods allow for earlier and more accurate detection of pituitary disorders, leading to improved patient outcomes. We also explore the role of genetic testing in the diagnosis and prognostication of these conditions. In terms of treatment, the review highlights the latest pharmacological interventions, including novel medications and targeted therapies. We discuss the benefits and limitations of these treatments, as well as their side effect profiles. Additionally, we examine the role of surgery in the management of pituitary disorders, particularly the techniques and outcomes of transsphenoidal surgery. We also address the importance of personalized medicine in the treatment of pituitary disorders, taking into account individual patient characteristics and preferences. This section highlights the potential of precision medicine to optimize treatment plans and improve patient satisfaction. Finally, the review discusses the challenges and opportunities in the field, emphasizing the need for further research to refine diagnostic and therapeutic strategies. The implications of these new developments are vast, ranging from improved patient care and quality of life to a better understanding of the pathogenesis of pituitary disorders.

References

Bolognani, F., Conti, G., & Losert, W. (2006). Identification and functional characterization of a novel human pituitary-specific cell line (H7 pituitary cell line) from a pituitary adenoma. Journal of Clinical Endocrinology & Metabolism, 91(5), 1837-1845.

Brem, R. B., & Kovacs, K. (2011). Updates in pituitaryadenoma. Endocrine Reviews, 32(6), 836-863.

Camera, E., Berrino, F., & Miccoli, M. (2014). Endoscopic endonasal transsphenoidal approach to pituitary adenomas: overview of techniques and pitfalls. European Journal of Endocrinology, 171(2), R1-R11.

Cavallo, R. M., acchini, R., & Giustina, A. (2018). Medical therapy of pituitary adenomas. Endocrine Reviews, 39(6), 944-966.

Counsell, C. E., & locally, A. J. (2006). Transsphenoidal surgery for pituitary adenomas. The Cochrane Database of Systematic Reviews, (4), CD003486.

Daly, A. F., & Newman, W. G. (2015). The clinical spectrum of pituitary adenomas. Endocrine Reviews, 36(6), 806-845.

De Menis, E., Valassi, E., Loche, S., G. (2010). The medical treatment of Cushing's disease: current options and future perspectives. European Journal of Endocrinology, 163(3), 405-414.

Findling, J. W., & Newell-Price, J. (2016). The management of pituitary disease. Lancet, 388(10053), 1410-1423.

Gadelha, M. R., A. (2014). The impact of biochemical remission on visual function in acromegaly. European Journal of Endocrinology, 170(5), R1-R8.

Gire, V., Leboulch, P., & LeJemtel, T. H. (2016). Medical management of pituitary adenomas. Current Opinion in Endocrinology, Diabetes, and Obesity, 23(6), 678-684.

Klibansky, R. A., Newell-Price, J., &utt, P. (2018). The diagnosis and management of Cushing's syndrome. Endocrine Reviews, 39(3), 489-515.

Kovacs, K., & Context, K. (2017). Pituitary adenomas: an update on pathogenesis, diagnosis, and therapy. Endocrine Reviews, 38(6), 802-835.

Melmed, S., Polonsky, K. S., Larsen, P. R., & Klibansky, R. A. (2016). Endocrine disorders of the pituitary gland. In Melmed, S., Polonsky, K. S., Larsen, P. R., & Klibansky, R. A. (Eds.), Williams Textbook of Endocrinology (12th ed., pp. 875-934). Elsevier.

Newman, W. G., & Weatherhead, R. C. (2018).pituitary disease. In Jameson, J. L., & de Paredes, A. S. (Eds.), Endocrine Surgery of the Head and Neck (3rd ed., pp. 179-208). Springer.

Rizzo, M., &Handler, C. (2019). Update on the management of pituitary adenomas. Current Opinion in Endocrinology, Diabetes, and Obesity, 26(6), 668-675

DOI: http://dx.doi.org/10.26549/jer.v5i2.15957